Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

Metastasis-Free Survival Viable Endpoint for Prostate Cancer Trials

Metastasis-free survival could be a surrogate endpoint for OS in clinical trials designed to evaluate adjuvant therapy options for patients with localized prostate cancer who are at a higher risk for death, according to a systematic review published in Journal of Clinical Oncology.

Read more.

source: Healio